Members |
targetComponentId |
Thyroid gland excision |
Thyroidectomy |
adjuvant tyroideahormonbehandling vid tyreostatikabehandling |
Administration of thyroid hormone adjunctive to antithyroid therapy (procedure) |
Thyroid related antibody |
Thyroid antibody |
tyreotropin alfa 0,9 mg/ml, pulver till injektionsvätska, flaska |
Thyrotrophin only product |
Thyrotropin alfa 1.1mg/vial powder |
Thyrotrophin only product |
Thyroxine sodium 100micrograms tablet |
Levothyroxine sodium anhydrous 100 microgram oral tablet |
Thyroxine sodium 25micrograms tablet |
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug) |
Thyroxine sodium 50micrograms tablet |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
tikarcillin 3 g + klavulansyra 100 mg, pulver till injektionsvätska, flaska |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
tikarcillindinatrium 1 g, pulver till injektionsvätska, flaska |
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
tikarcillindinatrium 20 g, pulver till injektionsvätska, flaska |
Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
tikarcillindinatrium 3 g, pulver till injektionsvätska, flaska |
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Tiludronate disodium |
Product containing tiludronic acid (medicinal product) |
Time since symptom started NOS |
Symptom findings in relation to start time |
Time since symptom started NOS |
Symptom findings in relation to start time |
Time symptom lasts NOS |
Symptom findings in relation to time lasts (finding) |
Time symptom lasts NOS |
Time symptom lasts |
Time zone syndrome |
Jet lag (finding) |
test av stående utan stöd med tidtagning |
Timed unsupported steady stand time |
timololmaleat 0,25 %, lösning för oftalmiskt bruk |
Timolol (as timolol maleate) 2.5 mg/mL eye drops |
Timolol maleate 0.5% |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
timololmaleat 0,5 %, lösning för oftalmiskt bruk |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Timolol maleate+bendroflumethiazide |
Product containing bendroflumethiazide and timolol (medicinal product) |
tiotropium 18 mikrogram, pulver till inhalationskapsel |
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Tiotropium 18microgram inhalation powder capsule with device |
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Tis (0): carcinoma in situ (begränsat till äggledarslemhinna) |
cTis |
Tis (0): carcinoma in situ (vagina) |
cTis |
Tis-stadium |
cTis |
Tis: carcinoma in situ ("platt tumör" i urinblåsa) |
cTis |
Tis: carcinoma in situ (endometrium/cervix) |
cTis |
Tis: Carcinoma in situ |
cTis |
Tis: endast epitel (carcinoma in situ, ingen inväxt) |
cTis |
Tis: intratubulär germinalcellsneoplasi (carcinoma in situ, testis) |
cTis |
Tis: tumörinväxt i lamina propria (gastrointestinal tumör) |
American Joint Committee on Cancer cTis(LAMN) (qualifier value) |
Tis: tumörinväxt i lamina mucosae (kolon/rektum) |
cTis |
Tissue culture for chromosome analysis, more complex procedure with special extra counts |
Chromosome analysis |
Tissue injection for local action |
Injection into body tissue for local action |
Tissue injection for local action NOS |
Injection into body tissue for local action |
Tissue injection for local action NOS |
Injection into body tissue for local action |
Tissue kallikrein |
Kininogen |
Tissue processing technique, complex, embed, cut and stain, per autopsy |
Tissue processing technique |
Tissue processing technique, complex, embed, cut and stain, per surgical specimen |
Tissue processing technique |
titandioxid 20 %, pasta |
Product containing only titanium dioxide (medicinal product) |
tobaksberoende med nuvarande användning |
Tobacco dependence syndrome |
tobramycin 0,3 %/fluorometolon 0,1 %, ögonsuspension |
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) |
tobramycin 1,2 g, pulver till injektionsvätska, flaska |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
Tobramycin 1.2mg/mL injection |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
tobramycin 300 mg/5 ml, lösning för nebulisator |
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
Tobramycin 60mg/mL solution |
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
tocilizumab 20 mg/ml, injektionsvätska, lösning |
Tocilizumab only product in parenteral dose form |
tocilizumab 20 mg/ml, vätska för intravenös infusion, lösning |
Tocilizumab only product in parenteral dose form |
Tocopherol |
Vitamin E and/or vitamin E derivative (substance) |
tålambå |
Flap (substance) |
Tolnaftate+chlorhexidine hydrochloride |
Product containing chlorhexidine and tolnaftate (medicinal product) |
Tolterodine 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
tolterodin L-tartrat 4 mg, kapsel med modifierad frisättning |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine L-tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
tolterodin L-tartrat 4 mg, depåkapsel |
Product containing only tolterodine in oral dose form (medicinal product form) |
tolterodintartrat 2 mg, kapsel med modifierad frisättning |
Product containing only tolterodine in oral dose form (medicinal product form) |
tolterodin L-tartrat 2 mg, depåkapsel |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
toluendiisocyanatspecifikt extrakt |
Toluene-2-4-diisocyanate |
tomat, livsmedel |
Tomato (substance) |
Tomilol |
Timolol (substance) |
Tomography - NOS |
Tomographic imaging procedure (procedure) |
Tomography - NOS |
Tomographic imaging procedure (procedure) |
tunglambå |
Flap (substance) |
tonisk-klonisk epilepsi |
Epilepsy |
Tonsil (& peritonsillar region) |
Palatine tonsillar structure |
Tooth attrition |
Excessive attrition of teeth |
Tooth decalcification |
Incipient enamel caries |
Tooth restoration NOS |
Restoration of tooth (procedure) |
Tooth restoration NOS |
Restoration of tooth (procedure) |
allergi mot lokala kombinationspreparat med dexametason |
Allergy to dexamethasone |
allergi mot lokalt kombinationspreparat med hydrokortison |
Allergy to hydrocortisone (finding) |
lokal kortikosteroid, grupp 1 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 2 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 3 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 4 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 5 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 6 |
Glucocorticoid (substance) |
biverkning av dermatologiskt preparat för lokalt bruk |
Adverse reaction to drug |
allergi mot lokal dexametason |
Allergy to dexamethasone |
allergi mot lokalt estradiol |
Allergy to estradiol (finding) |
allergi mot lokal hydrokortison |
Allergy to hydrocortisone (finding) |
allergi mot prednisolonpreparat för lokal behandling |
Allergy to prednisolone |
allergi mot lokal salicylsyra |
Allergy to salicylic acid (finding) |
selen för lokalt bruk |
Selenium |
svavel för lokal behandling |
Sulfur |
Topotecan 1mg powder for infusion solution vial |
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
Torday's elephant shrew |
Family Macroscelididae |
Toreks orkiopexioperation |
Orchidopexy |
torasemid 10 mg/ml, injektionsvätska, lösning, ampull |
Product containing only torasemide in parenteral dose form (medicinal product form) |
Torulopsis |
Candida |
Torulopsis candida |
Candida saitoana |
Torulopsis glabrata |
Candida glabrata (organism) |
Torulopsis pintolopesii |
Candida pintolopesii |
totalhalt biopteriner |
Substance with biopterin structure (substance) |
uppskattat dagligt totalt energiintag |
Estimated quantity of intake of energy in 24 hours (observable entity) |
Total excision of organ NOC |
Complete excision of organ (procedure) |
Tourette's disorder |
Gilles de la Tourette's syndrome |